MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML.

Published in:

British Journal of Haematology, 2011, v. 153, n. 6, p. 753, doi. 10.1111/j.1365-2141.2011.08662.x

By:

• Yin Xiong;
• Zejuan Li;
• Min Ji;
• Aik-Choon Tan;
• Bemis, Judson;
• Jove-Victor Tse;
• Gang Huang;
• Jino Park;
• Chunyan Ji;
• Jianjun Chen;
• Bemis, Lynne T.;
• Bunting, Kevin D.;
• Tse, William

Publication type:

Article